A Real-world study to evaluate the renal response rates with Carfilzomib versus Bortezomib in combination with Dexamethasone in Relapsed or Refractory Multiple Myeloma patients with Renal Impairment
Latest Information Update: 30 Jan 2019
At a glance
- Drugs Bortezomib (Primary) ; Carfilzomib (Primary) ; Dexamethasone
- Indications Multiple myeloma
- Focus Therapeutic Use
Most Recent Events
- 30 Jan 2019 New trial record
- 04 Dec 2018 Results presented at the 60th Annual Meeting and Exposition of the American Society of Hematology